BHEKISISA Six-monthly anti-HIV jab is coming, but can SA keep track of millions of users? 8 min 0 By Ida Jooste and Mia Malan
BHEKISISA Drugmakers to sell 6-monthly anti-HIV jab for the price of the daily HIV prevention pill 7 min 0 By Mia Malan
SPOTLIGHT OP-ED Long-acting HIV injections edge closer to widespread use in SA, but barriers remain 7 min 0 By Catherine Tomlinson for Spotlight
BHEKISISA Does SA need a Covid-like ministerial advisory committee to deal with HIV funding cuts? 6 min 0 By Mia Malan, Tanya Pampalone, Thatego Mashabela, Anna-Maria van Niekerk and Jessica Pitchford
BHEKISISA Study shows six-monthly anti-HIV jab could end Aids in South Africa by 2032 9 min 0 By Mia Malan
BHEKISISA The Global Fund will roll out the twice-yearly anti-HIV jab — with or without Pepfar 7 min 0 By Ida Jooste
BHEKISISA US embassy confirms Pepfar projects will restart — despite Trump’s aid ban in SA 3 min 0 By Mia Malan
HIV PREVENTION Viatris launches local ARV production in South Africa: a game changer for HIV treatment accessibility 4 min 0 By Naledi Sikhakhane
SPOTLIGHT OP-ED South Africa's HIV challenge: progress towards 2030 goals requires urgent action and innovation 5 min 0 By Salim Abdool Karim and Nikita Devnarain for Spotlight
SPOTLIGHT A call for urgent action in navigating the complex landscape of long-acting HIV medications 7 min 1 By Francois Venter
MEDICINE INEQUITIES OP-ED How South Africa can help secure immediate, global access to HIV prevention drug lenacapavir 5 min 1 By Tian Johnson, Fatima Hassan, Asia Russell and Sangeeta Shashikant
BHEKISISA Talks have started to get the twice-yearly anti-HIV jab registered in SA 3 min 1 By Mia Malan
SPOTLIGHT Efficacy of six-monthly HIV prevention jab confirmed in second major study 9 min 0 By Elri Voigt for Spotlight
BHEKISISA Almost 40% of the world’s anti-HIV pill users live in South Africa 10 min 2 By Mia Malan, Linda Pretorius and Zano Kunene
GENDER REDRESS OP-ED Empowering girls, ending HIV — a call to action on International Day of the Girl Child 4 min 0 By Eva Kiwango
SPOTLIGHT Why we don’t have long-acting HIV treatment in South Africa 7 min 0 By Elri Voigt for Spotlight
SPOTLIGHT Aids 2024 — exciting developments with the jabs promising to revolutionise HIV prevention 7 min 0 By Elri Voigt for Spotlight
BHEKISISA Lenacapavir — what it would it take to get the six-monthly anti-HIV jab to South Africa 9 min 0 By Mia Malan and Linda Pretorius
